Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Tillmann

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 2, 2007
Pradefovir, a liver-targeted prodrug of adefovir against HBV infectionHans L Tillmann
Metabolic Brain Disease|November 24, 2004
Hepatitis C virus infection and the brainHans L Tillmann
Nature Clinical Practice. Gastroenterology & Hepatology|September 13, 2007
Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?Hans L Tillmann
World Journal of Gastroenterology|June 20, 2014
Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatmentHans L Tillmann
Gastroenterology & Hepatology|March 26, 2011
The current status of thrombopoietins in the management of liver diseaseHans L Tillmann
The American Journal of Gastroenterology|September 19, 2025
Finite Treatments for Viral Hepatitis: Is "Sustained Control" Versus Cure Acceptable for HBV?Hans L Tillmann
Expert Review of Anti-Infective Therapy|December 18, 2012
Vitamins? The magic bullet against hepatitis CHans L Tillmann
The Journal of Infectious Diseases|October 16, 2013
Hepatitis C virus infection: when is a cure not a cure?Hans L Tillmann
Gastroenterology & Hepatology|August 25, 2010
ReviewHans L Tillmann
World Journal of Gastroenterology|January 9, 2007
Antiviral therapy and resistance with hepatitis B virus infectionHans L Tillmann
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Current Opinion in Investigational Drugs (London, England : 2000)|August 2, 2007
Pradefovir, a liver-targeted prodrug of adefovir against HBV infectionHans L Tillmann
Metabolic Brain Disease|November 24, 2004
Hepatitis C virus infection and the brainHans L Tillmann
Nature Clinical Practice. Gastroenterology & Hepatology|September 13, 2007
Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?Hans L Tillmann
World Journal of Gastroenterology|June 20, 2014
Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatmentHans L Tillmann
Gastroenterology & Hepatology|March 26, 2011
The current status of thrombopoietins in the management of liver diseaseHans L Tillmann
The American Journal of Gastroenterology|September 19, 2025
Finite Treatments for Viral Hepatitis: Is "Sustained Control" Versus Cure Acceptable for HBV?Hans L Tillmann
Expert Review of Anti-Infective Therapy|December 18, 2012
Vitamins? The magic bullet against hepatitis CHans L Tillmann
The Journal of Infectious Diseases|October 16, 2013
Hepatitis C virus infection: when is a cure not a cure?Hans L Tillmann
Gastroenterology & Hepatology|August 25, 2010
ReviewHans L Tillmann
World Journal of Gastroenterology|January 9, 2007
Antiviral therapy and resistance with hepatitis B virus infectionHans L Tillmann
Pageof 13